Anti-lung cancer synergy of low-dose doxorubicin and PD-L1 blocker co-delivered via mild photothermia-responsive black phosphorus. - Xu HZ; Chen FX; Li K; Zhang Q; Han N; Li TF; Xu YH; Chen Y; Chen X (Drug delivery and translational research, 2025)